Thank you for donating!

You can donate using the following services.

Our Friends

Here at NPUK you will regularly find us working with other like-minded organisations. We have a track-record of successful collaborations with organisations that share our focus and commitment to improving the lives of those affected with Niemann-Pick disease and other rare diseases.

We work and connect with other organisations both nationally and internationally, enabling us to develop a stronger, more united voice, to share knowledge and to access specialist information. Through our collaborations we will be able to achieve common goals, make a greater impact and accomplish more on behalf of those we support.

Our Friends

Support us

Latest news

08.09.16

CTD Holdings to Host Webinar to Provide Update on Trappsol® Cyclo™ Drug Development Program for Treatment of Niemann-Pick Disease Type C

CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced that it will host a webinar to provide details of the Company’s recently initiated Phase I clinical trial in the U.S. and Phase I/II clinical trial in the EU, both evaluating CTD’s proprietary formulation of hydroxypropyl beta cyclodextrin, Trappsol® Cyclo™, for the treatment of Niemann-Pick Disease Type C (NPC). NPC is a rare and fatal genetic disease that damages the brain, lung, liver, spleen, and other organs.

Read more

08.09.16

NPUK Annual Family Conference & Interactive Workshop 2017

We are looking forward to our next Annual Family Conference & Interactive Workshop, and we hope you are too! The event is the biggest in the NPUK calendar, and this year will be held 22nd-24th September 2017 at the Mercure Haydock Hotel, Merseyside, UK.

Read more
View all news Subscribe